Found: 5000
Select item for more details and to access through your institution.
Deucravacitinib: moderate-to-severe plaque psoriasis preventable?
- Published in:
- Journal of Basic & Clinical Physiology & Pharmacology, 2024, v. 35, n. 4/5, p. 225, doi. 10.1515/jbcpp-2023-0174
- By:
- Publication type:
- Article
Combination Therapy Consisting of Transarterial Chemoembolization, Lenvatinib, and Programmed Cell Death Protein 1 Blockade for Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombus: A Case Series Study and Literature Review.
- Published in:
- Oncology Research & Treatment, 2024, v. 47, n. 10, p. 465, doi. 10.1159/000540662
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis of Tucatinib in Healthy Participants and Patients with Breast Cancer or Colorectal Cancer.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 10, p. 1477, doi. 10.1007/s40262-024-01412-0
- By:
- Publication type:
- Article
Xanthohumol overcomes osimertinib resistance via governing ubiquitination-modulated Ets-1 turnover.
- Published in:
- Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-02220-y
- By:
- Publication type:
- Article
Radiotherapy plus lenvatinib versus radiotherapy plus sorafenib for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1458819
- By:
- Publication type:
- Article
New ABL1 Kinase Domain Mutations in BCR::ABL1‐Positive Acute Lymphoblastic Leukemia.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 20, p. 1, doi. 10.1002/cam4.70317
- By:
- Publication type:
- Article
Systemic treatments for radioiodine-refractory thyroid cancers.
- Published in:
- Frontiers in Endocrinology, 2024, p. 01, doi. 10.3389/fendo.2024.1346476
- By:
- Publication type:
- Article
ARAF Amplification in Small-Cell Lung Cancer-Transformed Tumors Following Resistance to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors.
- Published in:
- Cancers, 2024, v. 16, n. 20, p. 3501, doi. 10.3390/cancers16203501
- By:
- Publication type:
- Article
Comparing Lenvatinib/Pembrolizumab with Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma: A Real-World Experience with Propensity Score Matching Analysis.
- Published in:
- Cancers, 2024, v. 16, n. 20, p. 3458, doi. 10.3390/cancers16203458
- By:
- Publication type:
- Article
Chronic Phase Chronic Myeloid Leukemia: More Drugs, More Lives Saved, New Challenges.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Optimal First-Line Treatment of Chronic Myeloid Leukemia: How to Use Imatinib and What Role for Newer Drugs?
- Published in:
- Oncology (08909091), 2007, v. 21, n. 6, p. 653
- By:
- Publication type:
- Article
The Unfolding Story of Imatinib Mesylate for Chronic Myeloid Leukemia.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
New Therapeutics for Soft-Tissue Sarcomas in Adults.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 1, p. 123
- By:
- Publication type:
- Article
Anti-EGFR Therapies: Clinical Experience in Colorectal, Lung, and Head and Neck Cancers.
- Published in:
- Oncology (08909091), 2006, v. 20, p. 15
- By:
- Publication type:
- Article
EGFR Inhibitors in Lung Cancer.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 13, p. 1707
- By:
- Publication type:
- Article
Current Strategies in the Management of Lung Cancer.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 13, p. 1667
- By:
- Publication type:
- Article
Allogeneic stem cell transplant for chronic myeloid leukemia as a still promising option in the era of the new target therapy.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2012, v. 69, n. 1, p. 37, doi. 10.2298/VSP1201037S
- By:
- Publication type:
- Article
Faktori koji utiču na postizanje i postojanost citogenetskog odgovora kod bolesnika sa hroničnom mijeloidnom leukemijom na terapiji imatinibom.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2011, v. 68, n. 11, p. 911, doi. 10.2298/VSP1111911C
- By:
- Publication type:
- Article
Mastocytosis: Classification, Diagnosis, and Clinical Presentation.
- Published in:
- Allergy & Asthma Proceedings, 2004, v. 25, n. 1, p. 33
- By:
- Publication type:
- Article
Myocarditis Following Pembrolizumab Plus Axitinib, and Belzutifan Plus Lenvatinib for Renal Cell Carcinoma: A Case Report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Mitochondrial Dysfunction in Cardiotoxicity Induced by BCR-ABL1 Tyrosine Kinase Inhibitors -Underlying Mechanisms, Detection, Potential Therapies.
- Published in:
- Cardiovascular Toxicology, 2023, v. 23, n. 7/8, p. 233, doi. 10.1007/s12012-023-09800-x
- By:
- Publication type:
- Article
Cardiac Remodelling Following Cancer Therapy: A Review.
- Published in:
- Cardiovascular Toxicology, 2022, v. 22, n. 9, p. 771, doi. 10.1007/s12012-022-09762-6
- By:
- Publication type:
- Article
The Myocyte-Damaging Effects of the BCR-ABL1-Targeted Tyrosine Kinase Inhibitors Increase with Potency and Decrease with Specificity.
- Published in:
- Cardiovascular Toxicology, 2017, v. 17, n. 3, p. 297, doi. 10.1007/s12012-016-9386-7
- By:
- Publication type:
- Article
Determinants of Atrial Fibrillation Development among Patients undergoing Ibrutinib Therapy.
- Published in:
- Clinical Medicine & Research, 2022, v. 20, n. 1, p. 16, doi. 10.3121/cmr.2021.1693
- By:
- Publication type:
- Article
Investigation of the EGFR gene variations in bladder cancer patients using INFINITI Analyzer.
- Published in:
- Journal of Cell & Molecular Biology, 2011, v. 9, n. 1, p. 83
- By:
- Publication type:
- Article
Biology - Therapy.
- Published in:
- Current Medical Literature: Breast Cancer, 2011, v. 23, n. 2, p. 58
- Publication type:
- Article
Treatment -- Metastatic and Advanced Disease.
- Published in:
- Current Medical Literature: Breast Cancer, 2008, v. 20, n. 4, p. 124
- Publication type:
- Article
Simultaneous determination of nine tyrosine kinase inhibitors in three complex biological matrices by using high‐performance liquid chromatography–diode array detection combined with a second‐order calibration method.
- Published in:
- Journal of Separation Science, 2021, v. 44, n. 21, p. 3914, doi. 10.1002/jssc.202100293
- By:
- Publication type:
- Article
Synergy and Antagonism between Allosteric and Active‐Site Inhibitors of Abl Tyrosine Kinase.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 37, p. 20358, doi. 10.1002/ange.202105351
- By:
- Publication type:
- Article
Changes in clinical stage identify patients with CLL and different outcome within iwCLL partial response: RESONATE study.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 148, doi. 10.1111/bjh.15397
- By:
- Publication type:
- Article
Raman‐mikrospektroskopischer Nachweis für den Metabolismus eines Tyrosinkinase‐Inhibitors, Neratinib, in Krebszellen.
- Published in:
- Angewandte Chemie, 2018, v. 130, n. 24, p. 7370, doi. 10.1002/ange.201803394
- By:
- Publication type:
- Article
Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity—a perspective overview.
- Published in:
- BioMetals, 2024, v. 37, n. 2, p. 275, doi. 10.1007/s10534-023-00547-0
- By:
- Publication type:
- Article
Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients.
- Published in:
- Molecular Medicine, 2019, v. 25, n. 1, p. N.PAG, doi. 10.1186/s10020-019-0082-5
- By:
- Publication type:
- Article
Synthesis of imatinib, a tyrosine kinase inhibitor, labeled with carbon‐14.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2020, v. 63, n. 4, p. 174, doi. 10.1002/jlcr.3830
- By:
- Publication type:
- Article
One‐step synthesis of [<sup>18</sup>F]cabozantinib for use in positron emission tomography imaging of c‐Met.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2018, v. 61, n. 1, p. 11, doi. 10.1002/jlcr.3564
- By:
- Publication type:
- Article
Apoptotic profiling of chronic myeloid leukaemia patients' platelets ex vivo before and after treatment with Imatinib.
- Published in:
- Cell Biochemistry & Function, 2021, v. 39, n. 4, p. 562, doi. 10.1002/cbf.3625
- By:
- Publication type:
- Article
Imatinib Mesylate Does Not Increase Bone Volume In Vivo.
- Published in:
- Calcified Tissue International, 2011, v. 88, n. 1, p. 16, doi. 10.1007/s00223-010-9429-1
- By:
- Publication type:
- Article
Surufatinib-induced renal thrombotic microangiopathy: first case report and review of literature.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 483, n. 4, p. 561, doi. 10.1007/s00428-023-03545-2
- By:
- Publication type:
- Article
Multi-targeted tyrosine kinase inhibitor reverses resistance to immunotherapy in hepatic sarcomatoid carcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 20, p. 17849, doi. 10.1007/s00432-023-05491-7
- By:
- Publication type:
- Article
Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 19, p. 17651, doi. 10.1007/s00432-023-05437-z
- By:
- Publication type:
- Article
SLC12A8 mediates TKI resistance in EGFR-mutant lung cancer via PDK1/AKT axis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 18, p. 16729, doi. 10.1007/s00432-023-05416-4
- By:
- Publication type:
- Article
Characteristics, treatment patterns, and clinical outcomes in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertions.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 12, p. 10365, doi. 10.1007/s00432-023-04921-w
- By:
- Publication type:
- Article
Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 11, p. 9243, doi. 10.1007/s00432-023-04839-3
- By:
- Publication type:
- Article
Mutant-allele dispersion correlates with prognosis risk in patients with advanced non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 11, p. 8545, doi. 10.1007/s00432-023-04801-3
- By:
- Publication type:
- Article
Aggressive progression to EGFR tyrosine kinase inhibitors in advanced NSCLC patients: concomitant mutations, prognostic indicator and subsequent management.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 11, p. 8307, doi. 10.1007/s00432-023-04757-4
- By:
- Publication type:
- Article
A real-world study of the efficacy and safety of furmonertinib for patients with non-small cell lung cancer with EGFR exon 20 insertion mutations.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7729, doi. 10.1007/s00432-023-04726-x
- By:
- Publication type:
- Article
Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 6247, doi. 10.1007/s00432-022-04562-5
- By:
- Publication type:
- Article
Sustained response on sequential anti-FGFR therapy in metastatic gall bladder cancer: a case report and literature review.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4915, doi. 10.1007/s00432-022-04428-w
- By:
- Publication type:
- Article
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with recurrent non-small cell lung cancer after definitive concurrent chemoradiation or radiotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4243, doi. 10.1007/s00432-022-04287-5
- By:
- Publication type:
- Article
The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4141, doi. 10.1007/s00432-022-04252-2
- By:
- Publication type:
- Article